Biogen (BIIB) shares down 3% following Eli Lilly & Co. (LLY) failure of solanezumab data for Alzheimer's

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/24/2026

1. META
2. OKTA
3. P
4. MCD
5. ORCL
6. MGM
7. SPY
8. KGC
9. SFIX
10. GDDY

Go back to Biogen (BIIB) shares down 3% following Eli Lilly & Co. (LLY) failure of solanezumab data for Alzheimer's
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 225.83 -1.7 (0.75%)
Previous Close $227.53    52 Week High $333.65 
Open $226.80    52 Week Low $223.02 
Day High $228.72    P/E 28.92 
Day Low $224.31    EPS $7.81 
Volume 171,952